ANTM
Income statement / Annual
Last year (2024), Elevance Health Inc.'s total revenue was $177.01 B,
an increase of 27.68% from the previous year.
In 2024, Elevance Health Inc.'s net income was $5.97 B.
See Elevance Health Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2024 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$177.01 B |
$138.64 B |
$121.87 B |
$104.21 B |
$92.11 B |
$90.04 B |
$84.86 B |
$79.16 B |
$73.87 B |
$71.02 B |
| Cost of Revenue |
$19.75 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$157.26 B
|
$138.64 B
|
$121.87 B
|
$104.21 B
|
$92.11 B
|
$90.04 B
|
$84.86 B
|
$79.16 B
|
$73.87 B
|
$71.02 B
|
| Gross Profit Ratio |
0.89
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$13.36 B
|
$14.02 B
|
$11.25 B
|
$11.17 B
|
$11.09 B
|
$10.26 B
|
$8.43 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.40 B
|
$1.39 B
|
$1.44 B
|
$1.49 B
|
$1.53 B
|
| Selling, General & Administrative Expenses |
$0.00
|
$15.91 B
|
$17.45 B
|
$13.36 B
|
$14.02 B
|
$12.65 B
|
$12.56 B
|
$12.53 B
|
$11.75 B
|
$9.95 B
|
| Other Expenses |
$20.03 B
|
-$145.82 B
|
-$132.30 B
|
$84.12 B
|
$72.25 B
|
$72.41 B
|
$67.03 B
|
$61.35 B
|
$57.08 B
|
$56.48 B
|
| Operating Expenses |
$20.03 B
|
-$129.91 B
|
-$114.85 B
|
$97.48 B
|
$86.27 B
|
$85.06 B
|
$79.59 B
|
$73.88 B
|
$68.82 B
|
$66.44 B
|
| Cost And Expenses |
$39.78 B
|
$130.71 B
|
$115.63 B
|
$98.23 B
|
$87.04 B
|
$86.08 B
|
$80.31 B
|
$74.53 B
|
$69.51 B
|
$67.18 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.19 B
|
$798.00 M
|
$784.00 M
|
$746.00 M
|
$753.00 M
|
$739.00 M
|
$723.00 M
|
$653.00 M
|
$600.70 M
|
$602.70 M
|
| Depreciation & Amortization |
$0.00
|
$1.30 B
|
$1.15 B
|
$1.13 B
|
$1.13 B
|
$890.40 M
|
$911.80 M
|
$907.90 M
|
$851.00 M
|
$908.80 M
|
| EBITDA |
$137.24 B |
$10.03 B |
$19.34 B |
$7.86 B |
$6.95 B |
$5.59 B |
$6.19 B |
$6.19 B |
$5.83 B |
$5.21 B |
| EBITDA Ratio |
0.78
|
0.07
|
0.16
|
0.08
|
0.08
|
0.06
|
0.07
|
0.08
|
0.08
|
0.07
|
| Operating Income Ratio |
0.78
|
0.06
|
0.06
|
0.06
|
0.06
|
0.05
|
0.06
|
0.07
|
0.07
|
0.06
|
| Total Other Income/Expenses Net |
-$129.33 B
|
-$807.00 M
|
-$784.00 M
|
-$746.00 M
|
-$753.00 M
|
-$739.00 M
|
-$723.00 M
|
-$653.00 M
|
-$610.30 M
|
-$458.10 M
|
| Income Before Tax |
$7.90 B
|
$7.93 B
|
$6.24 B
|
$5.99 B
|
$5.07 B
|
$3.96 B
|
$4.56 B
|
$4.63 B
|
$4.37 B
|
$3.84 B
|
| Income Before Tax Ratio |
0.04
|
0.06
|
0.05
|
0.06
|
0.06
|
0.04
|
0.05
|
0.06
|
0.06
|
0.05
|
| Income Tax Expense |
$1.93 B
|
$1.83 B
|
$1.67 B
|
$1.18 B
|
$1.32 B
|
$121.00 M
|
$2.09 B
|
$2.07 B
|
$1.81 B
|
$1.21 B
|
| Net Income |
$5.97 B
|
$6.10 B
|
$4.57 B
|
$4.81 B
|
$3.75 B
|
$3.84 B
|
$2.47 B
|
$2.56 B
|
$2.57 B
|
$2.49 B
|
| Net Income Ratio |
0.03
|
0.04
|
0.04
|
0.05
|
0.04
|
0.04
|
0.03
|
0.03
|
0.03
|
0.04
|
| EPS |
25.81 |
24.84 |
18.63 |
19.01 |
14.57 |
15.01 |
9.36 |
9.8 |
9.58 |
8.49 |
| EPS Diluted |
25.68 |
23.97 |
17.98 |
18.47 |
14.19 |
14.35 |
9.21 |
9.38 |
8.99 |
8.2 |
| Weighted Average Shares Out |
$0.00
|
$245.40 M
|
$245.40 M
|
$252.92 M
|
$257.40 M
|
$256.08 M
|
$263.75 M
|
$261.24 M
|
$268.11 M
|
$293.27 M
|
| Weighted Average Shares Out Diluted |
$0.00
|
$254.30 M
|
$254.30 M
|
$260.30 M
|
$264.20 M
|
$267.80 M
|
$268.10 M
|
$272.90 M
|
$285.90 M
|
$303.80 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
